Top Story

Parker Institute for Cancer Immunotherapy awards grants to six early career researchers

April 5, 2020
FDA News

FDA grants orphan drug designation to several hematology/oncology therapies

HemOnc Today, March 25, 2020
The FDA has granted orphan drug designation to therapies for six hematology/oncology drug indications. These include:

12 medical centers form brain tumor research collaborative

March 22, 2020
Twelve institutions across the United States and Canada formed a collaborative designed to
In the Journals

Anticancer gene therapy regimen confers survival benefit in recurrent glioblastoma

March 18, 2020
Continued VB-111 monotherapy priming after progression with bevacizumab combination treatment improved survival outcomes among patients with recurrent glioblastoma…
More Headlines »